Delivery Order SPE2DE24D0013-SPE2D625F1GXD
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- The U.S. Defense Department's Medical Supply Chain awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 8, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which carries an ultimate completion date of August 15, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This award represents no set-aside designation and reflects the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- This delivery order, valued at $7,480, was awarded to Cepheid Inc. on September 12, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance expected at Cepheid's Sunnyvale, California facility and completion by September 26, 2025. The award utilizes firm fixed-price pricing with no set-aside designation, reflecting competitive procurement...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1GXDDelivery Order
This delivery order, awarded August 19, 2025, represents a firm fixed-price contract worth $8,160 for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order was issued to Cepheid Inc., a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and reagents for infectious disease detection. Performance will take place at Cepheid's Sunnyvale facility, with an ultimate completion date of August 26, 2025. The contract carries no set-aside designation and is funded through the Medical Supply Chain, a defense-oriented federal agency component. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, such as the Veterans Integrated Service Network 21 IDV valued at $2.5 million, which specifically covers PCR testing for laboratory microbiology including COVID-19, influenza, and RSV diagnostics. Cepheid has established itself as a primary supplier of molecular diagnostic solutions across multiple VA networks and the Defense Logistics Agency, with a track record of delivering diagnostic equipment, reagents, test kits, and associated maintenance services to support federal healthcare system testing and surveillance capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/19/25 |